MOLECULAR BASIS OF THALASSEMIA IN SLOVENIA

Similar documents
Thalassemias. Emanuela Veras, M.D. 01/08/2006

Thalassemias:general aspects and molecular pathology

Diagnostic difficulties in prevention and control program for thalassemia in Thailand: atypical thalassemia carriers

The diagnosis of Hemoglobinopathies

Cover Page. The handle holds various files of this Leiden University dissertation.

Haemoglobinopathies case studies 11 th Annual Sickle Cell and Thalassaemia Conference October 2017

Gamma gene expression in haemoglobin disorders

Comprehensive Hemoglobin Analysis HBA1/2 (

Screening for haemoglobinopathies in pregnancy

Dr. Ayman Mohsen Mashi, MBBS Consultant Hematology & Blood Transfusion Department Head, Laboratory & Blood Bank King Fahad Central Hospital, Gazan,

When do you have to perform the molecular biology in the hemoglobinopathies diagnosis

Report of Beta Thalassemia in Newar Ethnicity

Next Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters

Genetic Modifiers of Sickle Cell Disease Severity. Kunle Adekile, MD, PhD Professor Department of Pediatrics Kuwait University

db-thalassemia Patients With Homozygous Xmn-1 Polymorphism That Are Characterized By A Milder Phenotype

Genetics of Thalassemia

Unraveling Hemoglobinopathies with Capillary Electrophoresis

Hematologic Features of Alpha Thalassemia Carriers

DEVELOPMENT OF A HAEMOGLOBINOPATHY GENETIC DIAGNOSTIC SERVICE FOR THE NORTH WEST OF ENGLAND

Detecting and Reporting Alpha Thalassemia In Newborns

IJHOSCR. A Large Cohort Study of Genotype and Phenotype Correlations of Beta- Thalassemia in Iranian Population. Original Article

6.1 Extended family screening

HEMOGLOBIN ELECTROPHORESIS DR ARASH ALGHASI SHAFA HOSPITAL-AHWAZ

In adults, the predominant Hb (HbA) molecule has four chains: two α and two β chains. In thalassemias, the synthesis of either the α or the β chains

Counselling and prenatal diagnosis. Antonis Kattamis, Greece

Hemoglobinopathies Diagnosis and management

The Challenging Diagnosis of Treacherous Hemoglobinopathies

Genetic Modulation on the Phenotypic Diversity of Sickle Cell Disease

High Hemoglobin F in a Saudi Child Presenting with Pancytopenia

Haemoglobin Lepore in a Malay family: a case report

Line Probe Assay for Detection of Alpha Thalassemia: A Pilot Study

Corporate Medical Policy

Dr.Abdolreza Afrasiabi

Evaluation of the Molecular basis of KLF1 Gene in Iranian Thalassemia individuals with borderline hemoglobin A2

Anemia s. Troy Lund MSMS PhD MD

Beta Thalassemia Case Study Introduction to Bioinformatics

Hemoglobinopathy. Pathophysiology of β Thalassemia A Guide to Molecular Therapies. Swee Lay Thein

National Haemoglobinopathy Reference Laboratory. Information for Users

Current Topics in Hemoglobinopathies

EXTERNAL QUALITY ASSESSMENT FOR HAEMOGLOBIN A 2

Thalassemia Maria Luz Uy del Rosario, M.D.

The Thalassemias in Clinical Practice. Ashutosh Lal, MD Director Comprehensive Thalassemia Program UCSF Benioff Children s Hospital Oakland

Chapter 2 Genetic Basis and Genetic Modifiers of β-thalassemia and Sickle Cell Disease

Thalassemia intermedia in HbH-CS disease with compound heterozygosity for β-thalassemia: Challenges in hemoglobin analysis and clinical diagnosis

Epidemiological Study among Thalassemia Intermedia Pediatric Patients

IRON2009_CAP.10( ):EBMT :24 Pagina 250 CHAPTER 10. Molecular basis of thalassaemia syndromes. Bill Wood, Doug Higgs

Beta Thalassemia Frequency in Bahrain: A Ten Year Study. Shaikha Salim Al-Arrayed, MB,ChB, DHCG, PhD*

Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China

Prevalence of Thalassemia in Patients With Microcytosis Referred for Hemoglobinopathy Investigation in Ontario A Prospective Cohort Study

Pitfalls in the premarital testing for thalassaemia

b-globin Gene Cluster Haplotypes in Sickle Cell Patients From Southwest Iran

The Beats of Natural Sciences Issue 3-4 (September-December) Vol. 3 (2016)

Quiz. What percentage of the world s population is a carrier of a hemoglobinopathy? Hemoglobinopathies in Pregnancy 1-2% 5-7% 8-12% 10-15%

by Capillary Electrophoresis for Diagnosing β-thalassemia/ HbE Disease in Patients With Low HbF

Haemoglobin BY: MUHAMMAD RADWAN WISSAM MUHAMMAD

HbF<2% 95-98% H b A %

CRISPR-mediated Editing of Hematopoietic Stem Cells for the Treatment of β-hemoglobinopathies

Molecular Diagnosis of Thalassemias and Hemoglobinopathies. An ACLPS Critical Review CME/SAM. Daniel E. Sabath, MD, PhD ABSTRACT.

Screening and genetic diagnosis of haemoglobinopathies

Changes in hematological parameters in α-thalassemia individuals co-inherited with erythroid Krüppel-like factor mutations

Genetic Testing for α-thalassemia

GENETIC VARIATION OF THE BRCA1 AND BRCA2 GENES IN MACEDONIAN PATIENTS

An overview of Thalassaemias and Complications

BRITISH BIOMEDICAL BULLETIN

Haemoglobinopathy Case Studies. Dr Jill Finlayson Department of Haematology Pathwest Laboratory Medicine

Case Report Iron Depletion: An Ameliorating Factor for Sickle Cell Disease?

HEMOLYTIC ANEMIA DUE TO ABNORMAL HEMOGLOBIN SYNTHESIS

The Medical Genetics Unit

MICO Maggio 2016 Laboratory Diagnosis of Thalassemia

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Educational Items Section

HAEMOGLOBINOPATHIES. Editing file. References: 436 girls & boys slides 435 teamwork slides. Color code: Important. Extra.

George R. Honig Junius G. Adams III. Human Hemoglobin. Genetics. Springer-Verlag Wien New York

Hemolytic anemias (2 of 2)

A genetic score for the prediction of beta-thalassemia severity

Clinical Characteristics of Pediatric Thalassemia in Korea: A Single Institute Experience

REVIEWS PHENOTYPE GENOTYPE RELATIONSHIPS IN MONOGENIC DISEASE: LESSONS FROM THE THALASSAEMIAS. D. J. Weatherall

GENETIC FACTORS INFLUENCING HEMOGLOBIN

JMSCR Vol 06 Issue 01 Page January 2018

Research Article Pattern of β-thalassemia and Other Haemoglobinopathies: A Cross-Sectional Study in Bangladesh

DONE BY : RaSHA RAKAN & Bushra Saleem

Heme Questions and Derivatives for the USMLE Step One Exam. Winter Storm Skylar Edition

Beta Thalassemia Sami Khuri Department of Computer Science San José State University Spring 2015

New technologies for the diagnosis of thalassemia:

Journal of Medical Science & Technology

Hematopathology / SCREENING FOR THE (-- SEA ) ALPHA 0 -THALASSEMIA DELETION

Medical Policy. MP Genetic Testing for α-thalassemia. Related Policies Preimplantation Genetic Testing

Perspective on performance: The Haemoglobinopathies. Barbara Wild

CLINICAL AND HEMATOLOGICAL PHENOTYPE OF HOMOZYGOUS HEMOGLOBIN E: REVISIT OF A BENIGN CONDITION WITH HIDDEN REPRODUCTIVE RISK

The thalassemias refer to a diverse

Neonatal Screening for Genetic Blood Diseases. Shaikha Al-Arayyed, PhD* A Aziz Hamza, MD** Bema Sultan*** D. K. Shome, MRCPath**** J. P.

Hemoglobinopathy and thalassemia detection

What is Thalassaemia?

Dr Banu Kaya Consultant Haematologist Barts Health NHS Trust Royal London Hospital, London, UK SICKLE CELL AND THALASSAEMIA OVERVIEW

Cover Page. The handle holds various files of this Leiden University dissertation.

Evaluation of hemoglobinopathy screening results of a six year period in Turkey

4 Jumana Jihad Dr. Ahmad Mansour Dr. Ahmad Mansour

Supplementary Figure 1 Forest plots of genetic variants in GDM with all included studies. (A) IGF2BP2

Chem*3560 Lecture 4: Inherited modifications in hemoglobin

S-Beta Thalassemia leading to avascular necrosis of left hip joint in a young male - A rare case report

Transcription:

MOLECULAR BASIS OF THALASSEMIA IN SLOVENIA Dijana Plaseska-Karanfilska, MD, PhD Research Centre for Genetic Engineering and Biotechnology Georgi D. Efremov, Macedonian Academy of Sciences and Arts, Skopje, R. Macedonia 5 th Congress of Slovenian Hematological Society, Lasko, Slovenia, 07-09.2016

CONTENT Brief introduction Thalassemias in Slovenia Methodology Mutations Factors affecting fetal hemoglobin levels Slovenian db thalassemia patients

INTRODUCTION

THALASSEMIAS First recognized in 1925 in USA and Italy Widespread occurrence - from Africa and the Mediterranean region, through the Middle Eastern and Indian subcontinent, to Southern China and Southeast Asia Distribution parallels that of Plasmodium falciparum Inherited in a Mendelian recessive fashion Two main forms: a and b thalassemia

Hb TYPES, GLOBIN GENE CLUSTERS AND DEVELOPMENTAL EXPRESSION OF GLOBIN GENES Higgs et al., The Lancet 2012, 379:373

Genotype Phenotype BETA THALASSEMIA GENOTYPE/PHENOTYPE HETEROGENEITY Heterozygote Homozygote Compound heterozygote Carriers Intermedia Major Silent Hematologic phenotype Mild Tfx independent Severe sporadic Tfx Tfx dependent

Primary modifiers broad diversity of b globin gene mutations Secondary modifiers - involved in modifying the degree of globin chain imbalance (coinheritance of a-thal, a-triplication, increased g- chains) Tertiary modifiers effect on complications of the disease (genes involved in iron absorption, billirubin metabolism, bone metabolism, susceptibility to infection) Severity of b thal phenotype a thalassemia mild/silent b alleles increased g chains Imbalance in globin chain synthesis

THALASSEMIAS IN SLOVENIA

THALASSEMIAS IN SLOVENIA MATERIAL STUDIED Date No of samples Material Feb 2013 24 blood June 2013 15 blood Nov 2014 13 blood Feb 2016 20 DNA Total 72 Missing hematological data 5 (1 Normal) 3 (2 Normal) 1 (1 Normal) 6 (1 Normal) 15 (5 Normal) Missing HbA 2 & HbF values / / / 10 (3 Normal) 10 (3 Normal)

METHODS Protein analysis High Performance Liquid Chromatography (HPLC) Molecular characterization of thalassemia Multiplex Ligation Probe Amplification analysis (MLPA) Gap-PCR assays > Sicilian db deletion > Hb Lepore > α-globin deletions (α -3.7, α -med, α -20.5 ) > α-globin triplication ααα anti3.7 ) Multiplex SNaPshot analysis:common Mediterannean mutations Sequencing analysis: HBB, HBA 2, HBA 1, HBD genes

METHODS b-globin gene haplotypes 8 polymorphic sites in the b-globin gene cluster by PCR-RFLP Factors affecting fetal hemoglobin levels PCR-RFLP analysis : Gg Xmn1 polymorphic site Bcl11A polymorphic site High Resolution Melting analysis: MYB polymorphic site

THALASSEMIAS IN SLOVENIA Patients with thalassemia (n=53) 4% Unrelated patients with thlassemia (n=45) 2% 24% 72% deltabeta 29% beta alpha 69% deltabeta beta alpha

a-thalassemia Genotype No. of patients Ethnic origin Coinheritance - -(SEA)/aa 2 China (1) / a 3,7 /aa 1 Slovenia Sicilian db

Molecular characterization of a thalassemias MLPA analysis (a SEA deletion) Gap-PCR analysis

a THALASSEMIA DELETIONS Deletions of two a-genes (a 0 thalassaemia) Deletions of one a-gene (a + -thalassaemia) Hartveld & Higgs, Orphanet J Rare Dis 2010, 5:13.

DISTRIBUTION OF THE MOST COMMON a-thalassemia ALLELES Weatherall, DJ., Nature Reviews Genetics 2001;2(4):245-55.

b-thalassemia MUTATIONS Genotype No. of patients IVS-I-110G>A/N 5 Cd39C>T/N 5 IVS-II-745C>G/N 2 Ethnic origin Coinheritance Slovenia (4) Unknown (1) / Slovenia (4) Cuba (1) / Slovenia (1) Serbia (1) ααα anti3.7 (1) IVS-II-837T>G/N 1 Serbia (1) /

MOLECULAR CHARACTERIZATION OF b-thalassemia ALLELES HPLC analysis SNaPshot analysis Sequencing analysis

DISTRIBUTION OF THE MOST COMMON b-thalassemia ALLELES Weatherall, DJ., Nature Reviews Genetics 2001;2(4):245-55.

http://www.ithanet.eu IVS-I-110 G>A HGVS name Effect on gene/protein function Type of thalassemia Ethnic background Heterozygotes Homozygotes HBB:c.93-21G>A Cryptic splice site (mrna processing) Beta + thalassemia Mediterranean Mild anemia Transfusion dependent thalassemia major

http://www.ithanet.eu CD 39 C>T HGVS name Effect on gene/protein function Type of thalassemia Ethnic background Heterozygotes Homozygotes HBB:c.118C>T Nonsense codon (Translation) Beta 0 thalassemia Mediterranean Mild anemia Severe transfusion dependent thal major

http://www.ithanet.eu IVS-II-745 C>G HGVS name Effect on gene/protein function Type of thalassemia Ethnic background Heterozygotes Homozygotes HBB:c.316-106C>G Cryptic splice site (mrna processing) Beta + thalassemia Mediterranean Mild anemia Severe transfusion dependent thal major

IVS-II-837 T>G HGVS name HBB:c.316-14T>G Effect on gene/ protein function Type of thalassemia Ethnic background Cryptic splice site (mrna processing) Beta + or Beta 0 thalassemia (unclear) Asian Indian (rare mutation)

db-thalassemia IN SLOVENIA Genotype No. of patients HbF (%) Ethnic origin Coinheritance Haplotype Sicilian db Thal/N 33 4,6-17,7 Slovenia (32) Unknown (1) ααα anti3.7 (2) α 3.7 (1) I (VII) Lepore BW/N 5 2,4 4,4 Slovenia (3) Serbia (1) B&H (1) / V

b AND db CARRIERS WITH a TRIPLICATION b-thal Mutation a globin genes No. pat. Hb HCT MCV MCH Hb A2 Hb F IVS-II-745 aa/aa 1 12,8 38,0 63,6 20,9 4,5 0,9 IVS-II-745 aa/aaa 1 10,1 32,0 65 20,5 5,9 3,5 b-thal Mutation a globin genes No. pat Hb HCT MCV MCH Hb A2 Hb F Sicilian db aa/aa 25 12,1 37,3 67,3 21,5 2,4 8,4 Sicilian db aa/aaa 2 11,0 32,5 74,8 23,7 2,3 16,6

DELETIONS OF THE b-gobin GENE CLUSTER HPFH AND db THALASSEMIA Disorders of Hemoglobin, 2009

HPFH AND db THALASSEMIA db thalassemia HPFH Heterozygotes Hypochromia Microcytosis Normal A 2 (<3%) High HbF (5-15%) with heterocellular distribution Normal red cell indices Normal A 2 (<3%) Higher HbF (15-30%) with pancellular distribution Homozygotes Thalassemia intermedia Clinically normal with reduced MCV and MCH Compound heterozygotes with b thal Thalassemia major or intermedia Clinically very mild

HOW DO DELETIONS CAUSE RAISED HbF IN ADULTS Loss of regulatory regions Region between A g and d responsible for repressing g gene expression Competition between G g A g and db Globin gene expression involves interaction of LCR with gene promoters Promoter competition within the b-globin cluster Newly apposed enhancer sequences

MOLECULAR CHARACTERIZATION OF SICILIAN db THALASSEMIA HPLC analysis MLPA analysis Gap-PCR analysis

MOLECULAR CHARACTERIZATION OF LEPORE BOSTON WASHINGTON HPLC analysis Gap-PCR analysis

SICILIAN (db) 0 -THALASSEMIA HGVS name Mutation NG_000007.3:g.64336_77738del13403 Deletion of 13378 nts from the delta to beta gene Type of thalassemia δβ-thalassaemia; GγAγ(δβ) 0 Ethnic origin Heterozygote Homozygote Haplotype Mediterannean Sicily, Italy, former Yugoslavia, Hungary, Greece, Turkey, Israel, Egypt Mild anemia Thalassemia intermedia (mild form) I (VII)

HB LEPORE BOSTON WASHINGTON HGVS name NG_000007.3:g.63632_71046del Mutation Delta-beta hybrid (delta through 87; beta from 116) Type of thalassemia Ethnic background Heterozygotes Homozygotes Haplotype Hb variant and thalassemia (beta or deltabeta) Wordwide; the most common Hb Lepore type; found mainly in Italian families; it has also been observed in families from Romania, Yugoslavia, Turkey, Cyprus, Jamaica, Cuba, Greece, England, Australia, Mexico Mild anemia Variable (Thalassemia intermedia; thalassemia major) I, V

FACTORS AFFECTING HbF LEVELS

FETAL HEMOGLOBIN Strong modifier in hemoglobinopathies severity Variable and inducible quantitative trait in humans High levels are associated with thalassemia intermedia Mechanisms of gene expression and developmental gene regulation Targeted approaches for ameliorating severity of beta hemoglobinopathies

HB F VARIATION ASSOCIATED SNPs

SNPs ASSOCIATED WITH HIGH HbF - METHODS SNP XmnI (C>T) SNP BCL11A (T>C) RFLP analysis HBS1L-MYB (T>C) T/T T/C C/C HRM analysis

SNPs AFFECTING HbF IN SLOVENIAN SICILIAN db THALASSEMIA PATIENTS

SNPs AFFECTING HbF IN SLOVENIAN LEPORE BW PATIENTS

ITHANET WEBSITE http://www.ithanet.eu

ACKNOWLEDGEMENTS RCGEB Georgi D. Efremov, MASA Marija Dimishkovska Dr. Emilija Shukarova-Stefanovska Department of Hematology, University Medical Centre Ljubljana Prof. Peter Cernelc Dr. Biljana Todorova Clinic of Hematology, Medical Faculty, Skopje Prof. Oliver Karanfilski